Next Article in Journal
A Comprehensive Analysis of Postpartum Depression and Delivery Characteristics: A Cross-Sectional Study
Previous Article in Journal
Support for Family Members Who Are Caregivers to Relatives with Acquired Brain Injury
 
 
Journal of Mind and Medical Sciences is published by MDPI from Volume 12 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Valparaiso University (ValpoScholar).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Alexithymia and Physical Outcomes in Psychosomatic Subjects: A Cross-Sectional Study

by
Liam Alexander MacKenzie Myles
1 and
Emanuele Maria Merlo
2,*
1
Department of Psychology, Durham University, Durham, UK
2
Department of Adult and Childhood Human Pathology “Gaetano Barresi”, University of Messina, Italy
*
Author to whom correspondence should be addressed.
J. Mind Med. Sci. 2021, 8(1), 86-93; https://doi.org/10.22543/7674.81.P8693
Submission received: 14 September 2020 / Revised: 12 November 2020 / Accepted: 12 November 2020 / Published: 8 April 2021

Abstract

:
Backgrounds. Alexithymia is a relevant phenomenon, occurring transversally to healthy subjects and individuals affected by several conditions. Its role is considerable, according to current state of the art several conditions emerged as influenced, maintained and worsened by alexithymic structures and figures. The present study was aimed at highlighting the existing relations, the differences and the directions assumed by alexithymic factors and health status in patients affected by psychosomatic conditions. Methods. The sample consisted of 150 participants, 42 males (28.0%) and 108 females (72.0%), aged 26 to 78 years old with a mean of 42.24 years old (SD = 12.39). Subjects were previously assessed through DCPR-SI, in order to identify psychosomatic issues. The study evaluated measures related to alexithymia (Tas-20) and health status (SF-36), and considered demographic characteristics such as age, gender, and education. Results and Conclusions. The analyses demonstrated a number of significant relationships between alexithymia, psychological outcomes, and physical outcomes, including psychosomatic disorders. In addition, sex differences were found in gastrointestinal outcomes, as well as outcomes related to energy/fatigue and physical functioning. The study of alexithymia may provide a fruitful approach in understanding various issues related to pathology and general health. Further studies are needed to expand the understanding of alexithymia to other groups and health-related outcomes.

Introduction

“Alexithymia” describes a condition characterized by marked difficulty in indicating, describing, and being aware of emotions, the reduction of imagination, and a marked concern with concrete and detailed aspects of the external environment [1,2]. Theoretical and clinical interest in alexithymia has grown over the past decades, producing new perspectives while also revealing the need to improve constructs and refine clinical practice and useful psycho-diagnostics tools [3,4,5].
Alexithymia has a number of physical consequences [6,7,8], and it is associated with psychological characteristics that may have a direct role in the onset of various disorders and medical conditions [9,10,11,12,13,14,15,16]. These physical disorders include [17], but are not limited to, dermatological [18], cardiovascular [19,20] and gastrointestinal functional/structural issues [21,22,23]. Given that psychosomatic research has associated dermatological issues with psychological factors, it is not surprising that alexithymia may play a role [24,25,26,27,28]. A similar process may well be described for gastrointestinal, eating, and cardiovascular disorders [29,30,31,32,33,34,35]. In addition, the role of alexithymia in understanding a number of chronic conditions may be facilitated by understanding its relationship to specific psychological factors such as externally oriented thinking/operative thinking) and structures (psychosomatic order), suggesting a possible mediating role for such factors in chronic and worsening health conditions [36,37,38]. As such, alexithymia may play an increasingly important role in clinical practice [39,40,41].
Given the above, further study is needed to understand the role of alexithymia in different populations and for other psychological and physical/medical outcomes. In the present study, we assessed the relationship of alexithymia with a number of physical and psychological outcomes, including physical functioning, energy, fatigue, emotional well-being and general health status in subjects reporting psychosomatic outcomes.

Study hypotheses

To address the above goal, we carried out research that addressed three hypotheses. (1) demographic characteristics such as age and gender will be associated with alexithymia and health status. (2) various factors related to alexithymia will be associated with health status and psychosomatic outcomes. And (3) Differences will occur between male and female participants regarding health status and physical outcomes.

Materials and Methods

Participants

The sample consisted of 150 participants, 42 males (28.0%), and 108 females (72.0%), aged 26 to 78 years old with a mean of 42.24 years (SD = 12.39). Each participant completed the protocol, including providing information about education, gender, and age. Each participant, before providing informed consent, was informed about the anonymous nature of data collection process, consistent with the 1964 Declaration of Helsinki.

Instruments and procedure

Subjects were selected on the basis of their psychosomatic conditions, as evaluated by the Diagnostic Criteria for Psychosomatic Research Structured Interview- DCPR-SI [42,43], a structured interview containing a set of 12 syndromes of disease phobia, thanatophobia, health anxiety, illness denial, persistent somatization, functional somatic symptoms secondary to a psychiatric disorder, conversion symptoms, anniversary reaction, irritable mood, type A behaviour, demoralization, and alexithymia. According to Galeazzi et al. [44], the DCPR-SI indexes has high interrater reliability with kappa values of: Disease phobia, 0.97; Thanatophobia, 0.92; Type A behaviour, 0.92; Illness denial, 0.90; Demoralization, 0.90; Anniversary reaction, 0.90; Health anxiety, 0.89; Alexithymia, 0.89; Conversion symptoms, 0.82, Persistent somatization, 0.70; and Irritable mood, 0.69. Psychosomatic outcomes were considered on the basis of three main groups (assessed through a 10-point Likert scale, [17], as suggested by Picardi et al. (dermatological) [18], (cardiovascular) [19,20], (gastrointestinal) [21,22,23].
The Short Form Health Survey (SF-36) [45], Italian version by Apolone & Mosconi, 1998; Hays & Sherbourne, [46,47] regarding RAND Medical Outcomes Study, maintaining the same items) was used to study specific health dimensions: physical functioning, energy/fatigue, emotional well-being, general health. According to the validation study (adhering to RAND structure and factors), the various factors yielded the following alphas: physical functioning, 0.93, energy/fatigue, 0.86, emotional well-being, 0.90, general health, 0.78.
Toronto Alexithymia Scale [48] is a self-report instrument consisting of 20 items structured on a 5-points Likert scale. TAS-20 has demonstrated an internal consistency of 0.81 (Cronbach’s alphas), reporting a three factors structure (31% of the total variance), in particular Difficulty in Identifying Feelings (0.78), Difficulty in Describing Feelings (0.75), and Externally Oriented Thinking (0.66). Bressi et al. [49] published a cross validation of the Tas-20, including both clinical and non- clinical subjects. Alpha coefficient scores obtained with the non-clinic sample were 0.75 (full scale), and 0.77, 0.67 and 0.52 for the three factors; the clinical sample scores were 0.82 (full scale), and 0.79, 0.68 and 0.54 for the three factors. Subsequent research highlighted the good consistency and reliability of the three factors structure [50,51].

Statistical analysis

Numerical data were expressed as means and standard deviations, categorical variables as number and percentage. The Spearman test was used to evaluate correlations among alexithymia, health and psychosomatic variables of the following instruments. Student’s t-test compared gender groups, referring to health status and psychosomatic outcomes. A P-value smaller than 0.050 was considered to be statistically significant. All analyses were performed using SPSS 26.0 for Window package.

Results

Hypothesis 1

As noted in Table 2, age and education showed significant correlations with several assessment scores. Regarding age, significant and positive correlations emerged with Tas-20 total score, externally oriented thinking, and general health status. A negative and significant relation emerged with physical functioning. Regarding years of study, negative and significant relations emerged among years of study, Tas-20 total score, and energy-fatigue. The only positive correlation emerged was referred to physical functioning.
Table 1. Descriptive statistics.
Table 1. Descriptive statistics.
Jmms 08 00011 i001

Hypothesis 2

Hypothesis 2 was concerned with relationships among alexithymia (including related factors), health status, and psychosomatic outcomes. Results demonstrated significant positive relations with the onset of psychosomatic issues and negative significant correlations with health status (Table 3).
Regarding the Toronto Alexithymia Scale, significant negative correlations were found with physical functioning, energy/fatigue, emotional well-being, and general health status. Moreover, significant positive relationships emerged with gastrointestinal and cardiovascular outcomes. With regard to difficulty in identifying and describing feelings, significant negative correlations occurred with physical functioning, energy/fatigue, emotional well-being, and general health. Significant positive correlations emerged with dermatological, gastrointestinal, and cardiovascular outcomes, but no significant correlation was found between difficulty in describing feelings and dermatological outcomes. Externally oriented thinking was significantly and positively related to gastrointestinal and cardiovascular outcomes. In general, results concerning this second hypothesis highlighted relationships between alexithymia, negative health status, and increased psyc hosomatic issues.

Hypothesis 3

Hypotheses 3 was concerned with potential sex differences on a series of outcome variables (Table 4). Significant differences emerged on gastrointestinal outcomes, with higher scores in women, and on physical functioning and energy/fatigue, with higher scores in men.

Discussions

The current study examined relationships between alexithymia and health status using validated psycho- diagnostics tools, with results indicating a number of significant findings. In the first set of analyses, we considered the role of the demographic factors of age and education. Both variables were related to alexithymic total scores, as well as other specific physical and psychological outcomes, similar to a number of other studies [52,53,54,55,56,57]. In this respect, the first hypothesis was supported by our findings and also consistent with previously reported studies.
Regarding the second hypothesis, several significant findings emerged regarding the alexithymic domains and health status. As might be expected, physical, psychological, and general health were negatively related to higher alexithymic symptoms. In contrast, higher alexithymic scores were related to increased psychosomatic outcomes, including dermatological, cardiovascular, and gastrointestinal.
Regarding dermatological outcomes, the results suggested the strong link with the first alexithymic factor, that is, difficulty in identifying feelings. Such a link has been previously documented by research on psychosomatics and dermatological issues, as in the case of psoriasis, vitiligo, and other relevant illnesses [58,59,60,61]. Gastrointestinal and cardiovascular outcomes were even more strongly related to alexithymia, relationships also strongly reported in the literature [23,62,63,64,65,66].
The third hypothesis was concerned with differences in physical outcomes and health status between men and women. Some significant differences emerged, with higher scores in men on physical functioning and energy/fatigue, and higher scores in women on gastrointestinal disorders. These findings are consistent with other recent studies showing relationships between gastrointestinal outcomes and alexithymic functioning [21,23,67,68,69,70].
Current research on alexithymia has the potential for integrating findings over psychological and biological domains, which are often viewed as distinct entities [71,72,73,74,75]. Several authors have addressed this dichotomy, so it would be fundamental to try to reach integrity overcoming theoretical oppositions. In addition to Damasio’s earlier studies [76,77], more recent contributions have taken up the issue [78,79,80], suggesting ways to reframe classical perspectives through objective methods and rigorous analyses.

Conclusions

The current study investigated the relationship between alexithymia, demographic variables, and specific health outcomes using validated instruments. Results indicated that alexithymia may play a role in a variety of health outcomes, including gastrointestinal problems, and decreased physical and energy status. Subsequent studies should expand the observation group and balance gender groups, as well as use research designs that enable stronger inferences regarding causal relationships.

Conflicts of Interest disclosure

There are no known conflicts of interest in the publication of this article. The manuscript was read and approved by all authors.

Compliance with ethical standards

Any aspect of the work covered in this manuscript has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript.

References

  1. Gregory, R.J.; Berry, S.L. Measuring counterdependency in patients with chronic pain. Psychosom Med. 1999, 61, 341–345. [Google Scholar] [CrossRef] [PubMed]
  2. Sifneos, P.E. The prevalence of ‘alexithymic’ characteristics in psychosomatic patients. Psychother Psychosom. 1973, 22, 255–262. [Google Scholar] [CrossRef] [PubMed]
  3. Šago, D.; Babić, G. Roots of Alexithymia. Arch. Psychiatry Res. Int. J. Psychiatry Relat. Sci. 2019, 55, 71–84. [Google Scholar] [CrossRef]
  4. Taylor, G.J. Recent developments in alexithymia theory and research. Can J Psychiatry. 2000, 45, 134–142. [Google Scholar] [CrossRef]
  5. Widge, A.S.; Dougherty, D.D.; Moritz, C.T. Affective Brain-Computer Interfaces As Enabling Technology for Responsive Psychiatric Stimulation. Brain Comput Interfaces (Abingdon). 2014, 1, 126–136. [Google Scholar] [CrossRef]
  6. Porcelli, P.; Taylor, G. Alexithymia and Physical Illness: A Psychosomatic Approach. In Alexithymia: Advances in Research, Theory, and Clinical Practice; Luminet, O., Bagby, R., Taylor, G., Eds.; Cambridge University Press: Cambridge, UK, 2018; pp. 105–126. [Google Scholar] [CrossRef]
  7. Terock, J.; Klinger-König, J.; Janowitz, D.; Nauck, M.; Völzke, H.; Grabe, H.J. Alexithymia is associated with increased all-cause mortality risk in men, but not in women: A 10-year follow-up study. J Psychosom Res. 2021, 143, 110372. [Google Scholar] [CrossRef]
  8. Torrado, M.; Eusébio, S.; Ouakinin, S. Alexithymia and illness: Towards a psychosomatic perspective of emotion regulation deficits. In Perspectives on Cognitive Psychology. Current developments in alexithymia: A cognitive and affective deficit; Teixeira, R.J., Bermond, B., Moormann, P.P., Eds.; Nova Science Publishers: Hauppauge, NY, USA, 2018; pp. 173–194. [Google Scholar]
  9. Conversano, C. Common Psychological Factors in Chronic Diseases. Front Psychol. 2019, 10, 2727. [Google Scholar] [CrossRef]
  10. Conversano, C.; Di Giuseppe, M. Psychological Factors as Determinants of Chronic Conditions: Clinical and Psychodynamic Advances. Front Psychol. 2021, 12, 635708. [Google Scholar] [CrossRef]
  11. Hyphantis, T.; Goulia, P.; Carvalho, A.F. Personality traits, defense mechanisms and hostility features associated with somatic symptom severity in both health and disease. J Psychosom Res. 2013, 75, 362–369. [Google Scholar] [CrossRef]
  12. Di Giuseppe, M.; Ciacchini, R.; Micheloni, T.; Bertolucci, I.; Marchi, L.; Conversano, C. Defense mechanisms in cancer patients: A systematic review. J Psychosom Res. 2018, 115, 76–86. [Google Scholar] [CrossRef]
  13. Martino, G.; Langher, V.; Cazzato, V.; Vicario, C.M. Editorial: Psychological Factors as Determinants of Medical Conditions. Front Psychol. 2019, 10, 2502. [Google Scholar] [CrossRef] [PubMed]
  14. Kramer, G.P.; Bernstein, D.A.; Phares, V. Introduction to clinical psychology; Cambridge University Press: Cambridge, UK, 2019; ISBN-10: 1108705146. [Google Scholar]
  15. Hunsley, J.; Lee, C.M. Introduction to clinical psychology; John Wiley & Sons: Hoboken, NJ, USA, 2017; ISBN 978-1-119-30151-6. [Google Scholar]
  16. Merlo, E.M. Opinion Article: The role of psychological features in chronic diseases, advancements and perspectives. Mediterr. J. Clin. Psychol. 2019, 7. [Google Scholar] [CrossRef]
  17. Settineri, S.; Frisone, F.; Alibrandi, A.; Merlo, E.M. Emotional Suppression and Oneiric Expression in Psychosomatic Disorders: Early Manifestations in Emerging Adulthood and Young Patients. Front Psychol. 2019, 10, 1897. [Google Scholar] [CrossRef]
  18. Picardi, A.; Abeni, D.; Melchi, C.F.; Puddu, P.; Pasquini, P. Psychiatric morbidity in dermatological outpatients: An issue to be recognized. Br J Dermatol. 2000, 143, 983–991. [Google Scholar] [CrossRef] [PubMed]
  19. Grandi, S.; Fabbri, S.; Tossani, E.; Mangelli, L.; Branzi, A.; Magelli, C. Psychological Evaluation after Cardiac Transplantation: The Integration of Different Criteria. Psychother Psychosom. 2001, 70, 176–183. [Google Scholar] [CrossRef]
  20. Vadini, F.; Sozio, F.; Madeddu, G.; De Socio, G.; Maggi, P.; Nunnari, G.; Vichi, F.; Di Stefano, P.; Tracanna, E.; Polilli, E.; Sciacca, A.; Zizi, B.; Lai, V.; Bartolozzi, C.; Flacco, M.E.; Bonfanti, P.; Santilli, F.; Manzoli, L.; Parruti, G. Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study. Open Forum Infect Dis. 2019, 6, ofz331. [Google Scholar] [CrossRef] [PubMed]
  21. Porcelli, P.; Taylor, G.J.; Bagby, R.M.; De Carne, M. Alexithymia and functional gastrointestinal disorders. A comparison with inflammatory bowel disease. Psychother Psychosom. 1999, 68, 263–269. [Google Scholar] [CrossRef]
  22. Kano, M.; Muratsubaki, T.; Yagihashi, M.; Morishita, J.; Mugikura, S.; Dupont, P.; Takase, K.; Kanazawa, M.; Van Oudenhove, L.; Fukudo, S. Insula Activity to Visceral Stimulation and Endocrine Stress Responses as Associated With Alexithymia in Patients With Irritable Bowel Syndrome. Psychosom Med. 2020, 82, 29–38. [Google Scholar] [CrossRef]
  23. Kano, M.; Endo, Y.; Fukudo, S. Association Between Alexithymia and Functional Gastrointestinal Disorders. Front Psychol. 2018, 9, 599. [Google Scholar] [CrossRef]
  24. Baysak, S.; Kılıç, F.A.; Karagün, E.; Baysak, E. Relationship of Alexithymia, Rumination and Coping Style with Psoriasis and Their Effects on The Clinical Features. Turk Psikiyatri Derg. 2020, 31, 252–258. [Google Scholar]
  25. Craparo, G.; Magnano, P.; Zapparrata, M.V.; Gori, A.; Costanzo, G.; Pace, U.; Pellerone, M. Coping, attachment style and resilience: The mediating role of alexithymia. Mediterr. J. Clin. Psychol. 2018, 6. [Google Scholar] [CrossRef]
  26. Hemming, L.; Haddock, G.; Shaw, J.; Pratt, D. Alexithymia and Its Associations With Depression, Suicidality, and Aggression: An Overview of the Literature. Front Psychiatry 2019, 10, 203. [Google Scholar] [CrossRef] [PubMed]
  27. Talamonti, M.; Galluzzo, M.; Servoli, S.; D’Adamio, S.; Bianchi, L. Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients. Dermatology 2016, 232, 648–654. [Google Scholar] [CrossRef]
  28. Willemsen, R.; Roseeuw, D.; Vanderlinden, J. Alexithymia and dermatology: The state of the art. Int J Dermatol. 2008, 47, 903–910. [Google Scholar] [CrossRef] [PubMed]
  29. Carney, R.M.; Rich, M.W.; Freedland, K.E.; Saini, J.; teVelde, A.; Simeone, C.; Clark, K. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 1988, 50, 627–633. [Google Scholar] [CrossRef]
  30. Craparo, G.; Gagliano, O.; Costanzo, G.; La Rosa, V.L.; Gori, A.; Mendolicchio, L. Boredom, alexithymia, and desire thinking in eating disorders: A cross-sectional study. Mediterr. J. Clin. Psychol. 2020, 8. [Google Scholar] [CrossRef]
  31. Frasure-Smith, N.; Lespérance, F.; Talajic, M. Depression following myocardial infarction. Impact on 6-month survival. JAMA. 1993, 270, 1819–1825. [Google Scholar] [CrossRef]
  32. Kojima, M.; Frasure-Smith, N.; Lespérance, F. Alexithymia following myocardial infarction: Psychometric properties and correlates of the Toronto Alexithymia Scale. J Psychosom Res. 2001, 51, 487–495. [Google Scholar] [CrossRef]
  33. Martino, G.; Caputo, A.; Schwarz, P.; Bellone, F.; Fries, W.; Quattropani, M.C.; Vicario, C.M. Alexithymia and Inflammatory Bowel Disease: A Systematic Review. Front Psychol. 2020, 11, 1763. [Google Scholar] [CrossRef]
  34. Mazaheri, M.; Afshar, H.; Weinland, S.; Mohammadi, N.; Adibi, P. Alexithymia and functional gastrointestinal disorders (FGID). Med Arh. 2012, 66, 28–32. [Google Scholar] [CrossRef]
  35. Porcelli, P.; Leoci, C.; Guerra, V.; Taylor, G.J.; Bagby, R.M. A longitudinal study of alexithymia and psychological distress in inflammatory bowel disease. J Psychosom Res. 1996, 41, 569–573. [Google Scholar] [CrossRef]
  36. Martino, G.; Caputo, A.; Vicario, C.M.; Catalano, A.; Schwarz, P.; Quattropani, M.C. The Relationship Between Alexithymia and Type 2 Diabetes: A Systematic Review. Front Psychol. 2020, 11, 2026. [Google Scholar] [CrossRef]
  37. Özsoy, F.; Taşcı, İ. Defense mechanisms, dissociation, alexithymia and childhood traumas in chronic migraine patients. Journal of Rational-Emotive & Cognitive- Behavior Therapy 2021, 39, 1–13. [Google Scholar] [CrossRef]
  38. Pappalardo, S.M. Vlad-Virtual Reality Application for Treatment of Psychosomatic Conditions: A report at final stage of software validation process. Mediterr. J. Clin. Psychol. 2020, 8. [Google Scholar] [CrossRef]
  39. De Vries, A.M.M.; Gholamrezaee, M.M.; Verdonck-de Leeuw, I.M.; de Roten, Y.; Despland, J.N.; Stiefel, F.; Passchier, J. Physicians’ emotion regulation during communication with advanced cancer patients. Psychooncology 2018, 27, 929–936. [Google Scholar] [CrossRef] [PubMed]
  40. Merlo, E.M.; McNabney, S.M.; Frisone, F.; Sicari, F.; Paunica, M.; Motofei, C.; Settineri, S. Compassion and suppression in caregivers: Twin masks of tragedy and joy of caring. J Mind Med Sci. 2020, 7, 61–68. [Google Scholar] [CrossRef]
  41. Merlo, E.M.; Stoian, A.P.; Motofei, I.G.; Settineri, S. Clinical Psychological Figures in Healthcare Professionals: Resilience and Maladjustment as the "Cost of Care". Front Psychol. 2020, 11, 607783. [Google Scholar] [CrossRef]
  42. Fava, G.A.; Freyberger, H.J.; Bech, P.; Christodoulou, G.; Sensky, T.; Theorell, T.; Wise, T.N. Diagnostic criteria for use in psychosomatic research. Psychother Psychosom. 1995, 63, 1–8. [Google Scholar] [CrossRef]
  43. Porcelli, P.; Sonino, N. Psychological Factors Affecting Medical Conditions: A New Classification for DSM-V; Karger Medical and Scientific Publishers: Basel, Switzerland, 2007; Volume 28. [Google Scholar] [CrossRef]
  44. Galeazzi, G.M.; Ferrari, S.; Mackinnon, A.; Rigatelli, M. Interrater reliability, prevalence, and relation to ICD-10 diagnoses of the Diagnostic Criteria for Psychosomatic Research in consultation-liaison psychiatry patients. Psychosomatics 2004, 45, 386–393. [Google Scholar] [CrossRef]
  45. Ware, J.E.; Snow, K.K.; Kosinski, M.; Gandek, B. SF-36 health survey. Manual and interpretation guide; The Health Institute, New England Medical Center: Boston, MA, USA, 1997; p. 10-6. [Google Scholar]
  46. Apolone, G.; Mosconi, P. The Italian SF-36 Health Survey: Translation, validation and norming. J Clin Epidemiol. 1998, 51, 1025–1036. [Google Scholar] [CrossRef]
  47. Hays, R.D.; Sherbourne, C.D.; Mazel, R.M. The RAND 36-Item Health Survey 1.0. Health Econ. 1993, 2, 217–227. [Google Scholar] [CrossRef] [PubMed]
  48. Bagby, R.M.; Parker, J.D.; Taylor, G.J. The twenty-item Toronto Alexithymia Scale--I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994, 38, 23–32. [Google Scholar] [CrossRef] [PubMed]
  49. Gritti, P.; Lombardi, S.; Nobile, B.; Trappoliere, P.; Gambardella, A.; Di Caprio, E.L.; Resicato, G. Alexithymia and cancer-related fatigue: A controlled cross-sectional study. Tumori. 2010, 96, 131–137. [Google Scholar]
  50. Theisen, M.E.; MacNeill, S.E.; Lumley, M.A.; Ketterer, M.W.; Goldberg, A.D.; Borzak, S. Psychosocial factors related to unrecognized acute myocardial infarction. Am J Cardiol. 1995, 75, 1211–1213. [Google Scholar] [CrossRef]
  51. Craparo, G.; Faraci, P.; Gori, A. Psychometric Properties of the 20-Item Toronto Alexithymia Scale in a Group of Italian Younger Adolescents. Psychiatry Investig. 2015, 12, 500–507. [Google Scholar] [CrossRef]
  52. Kauhanen, J.; Kaplan, G.A.; Julkunen, J.; Wilson, T.W.; Salonen, J.T. Social factors in alexithymia. Compr Psychiatry. 1993, 34, 330–335. [Google Scholar] [CrossRef] [PubMed]
  53. Kirmayer, L.J.; Robbins, J.M. Cognitive and social correlates of the Toronto Alexithymia Scale. Psychosomatics. 1993, 34, 41–52. [Google Scholar] [CrossRef]
  54. Marty, P. L’ordre psychosomatique (PAYOT) (French) Paperback–September 17 1998; ISBN-10: 2228891819.
  55. Motofei, I.G. The etiology of premature ejaculation starting from a bihormonal model of normal sexual stimulation. Int J Impot Res. 2001, 13, 49–50. [Google Scholar] [CrossRef]
  56. Taylor, G.J.; Bagby, R.M. Examining Proposed Changes to the Conceptualization of the Alexithymia Construct: The Way Forward Tilts to the Past. Psychother Psychosom. 2020, 7, 1–11. [Google Scholar] [CrossRef]
  57. Goerlich, K.S. The Multifaceted Nature of Alexithymia- A Neuroscientific Perspective. Front Psychol. 2018, 9, 1614. [Google Scholar] [CrossRef]
  58. Cupertino, F.; Niemeyer-Corbellini, J.P.; Ramos-E-Silva, M. Psychosomatic aspects of vitiligo. Clin Dermatol. 2017, 35, 292–297. [Google Scholar] [CrossRef]
  59. Gieler, U.; Gieler, T.; Peters, E.M.J.; Linder, D. Skin and Psychosomatics—Psychodermatology today. J Dtsch Dermatol Ges. 2020, 18, 1280–1298. [Google Scholar] [CrossRef] [PubMed]
  60. Mulinari-Brenner, F. Psychosomatic aspects of alopecia areata. Clin Dermatol. 2018, 36, 709–713. [Google Scholar] [CrossRef] [PubMed]
  61. Zięciak, T.; Rzepa, T.; Król, J.; Żaba, R. Stigmatization feelings and depression symptoms in psoriasis patients. Psychiatr Pol. 2017, 51, 1153–1163. [Google Scholar] [CrossRef] [PubMed]
  62. Aluja, A.; Malas, O.; Urieta, P.; Worner, F.; Balada, F. Biological correlates of the Toronto Alexithymia Scale (TAS-20) in cardiovascular disease and healthy community subjects. Physiol Behav. 2020, 227, 113151. [Google Scholar] [CrossRef]
  63. Karukivi, M.; Jula, A.; Pulkki-Råback, L.; Hutri-Kähönen, N.; Laitinen, T.T.; Viikari, J.; Juonala, M.; Raitakari, O. Ideal cardiovascular health in adolescents and young adults is associated with alexithymia over two decades later: Findings from the cardiovascular risk in Young Finns Study: Department: Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland. Psychiatry Res. 2020, 289, 112976. [Google Scholar] [CrossRef]
  64. Motofei, I.G. A dual physiological character for cerebral mechanisms of sexuality and cognition: Common somatic peripheral afferents. BJU Int. 2011, 108, 1634–1639. [Google Scholar] [CrossRef]
  65. Xiong, N.N.; Wei, J.; Ke, M.Y.; Hong, X.; Li, T.; Zhu, L.M.; Sha, Y.; Jiang, J.; Fischer, F. Illness Perception of Patients with Functional Gastrointestinal Disorders. Front Psychiatry. 2018, 9, 122. [Google Scholar] [CrossRef]
  66. Wiernik, E.; Lemogne, C.; Fezeu, L.; Arnault, N.; Hercberg, S.; Kesse-Guyot, E.; Galan, P. Association Between Alexithymia and Risk of Incident Cardiovascular Diseases in the SUpplémentation en VItamines et Minéraux AntioXydants (SU.VI.MAX) Cohort. Psychosom Med. 2018, 80, 460–467. [Google Scholar] [CrossRef]
  67. Adeyemo, M.A.; Spiegel, B.M.; Chang, L. Meta-analysis: Do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther. 2010, 32, 738–755. [Google Scholar] [CrossRef]
  68. Kanazawa, M.; Endo, Y.; Whitehead, W.E.; Kano, M.; Hongo, M.; Fukudo, S. Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci. 2004, 49, 1046–1053. [Google Scholar] [CrossRef]
  69. Kosako, M.; Akiho, H.; Miwa, H.; Kanazawa, M.; Fukudo, S. Impact of symptoms by gender and age in Japanese subjects with irritable bowel syndrome with constipation (IBS-C): A large population-based internet survey. Biopsychosoc Med. 2018, 12, 12. [Google Scholar] [CrossRef]
  70. Löwe, B.; Lohse, A.; Andresen, V.; Vettorazzi, E.; Rose, M.; Broicher, W. The Development of Irritable Bowel Syndrome: A Prospective Community-Based Cohort Study. Am J Gastroenterol. 2016, 111, 1320–1329. [Google Scholar] [CrossRef]
  71. Demers, L.A.; Schreiner, M.W.; Hunt, R.H.; Mueller, B.A.; Klimes-Dougan, B.; Thomas, K.M.; Cullen, K.R. Alexithymia is associated with neural reactivity to masked emotional faces in adolescents who self-harm. J Affect Disord. 2019, 249, 253–261. [Google Scholar] [CrossRef] [PubMed]
  72. Donges, U.S.; Suslow, T. Alexithymia and automatic processing of emotional stimuli: A systematic review. Rev Neurosci. 2017, 28, 247–264. [Google Scholar] [CrossRef] [PubMed]
  73. Lane, R.D. Is it possible to bridge the Biopsychosocial and Biomedical models? Biopsychosoc Med. 2014, 8, 3. [Google Scholar] [CrossRef]
  74. Meza-Concha, N.; Arancibia, M.; Salas, F.; Behar, R.; Salas, G.; Silva, H.; Escobar, R. Towards a neurobiological understanding of alexithymia. Medwave. 20 1729, 17, e6960. [Google Scholar] [CrossRef]
  75. Patrikelis, P.; Lucci, G.; Alexoudi, A.; Korfias, S.; Messinis, L.; Nasios, G.; Papasilekas, T.; Sakas, D.; Gatzonis, S. Addressing Evidence Linking Secondary Alexithymia to Aberrant Humor Processing. Behav Neurol. 2019, 2019, 1803624. [Google Scholar] [CrossRef]
  76. Damasio, A.R. Descartes’ error and the future of human life. Sci Am. 1994, 271, 144. [Google Scholar] [CrossRef]
  77. Damasio, A.R. Descartes’ error revisited. J Hist Neurosci. 2001, 10, 192–194. [Google Scholar] [CrossRef]
  78. Kastrup, B. An ontological solution to the mind-body problem. Philosophies. 2017, 2, 10. [Google Scholar] [CrossRef]
  79. Motofei, I.G.; Rowland, D.L. Solving the mind-body problem through two distinct concepts: Internal-mental existence and internal mental reality. J Mind Med Sci. 2015, 2, 128–141. [Google Scholar]
  80. Motofei, I.G.; Rowland, D.L. The mind-body problem; three equations and one solution represented by immaterial-material data. J Mind Med Sci. 2018, 5, 59–69. [Google Scholar] [CrossRef]
Table 2. Spearman correlation coefficients among Hp-1 variables.
Table 2. Spearman correlation coefficients among Hp-1 variables.
Jmms 08 00011 i002
Table 3. Spearman correlation coefficients among Hp-2 variables.
Table 3. Spearman correlation coefficients among Hp-2 variables.
Jmms 08 00011 i003
Table 4. Comparison between male and female groups.
Table 4. Comparison between male and female groups.
Jmms 08 00011 i004

Share and Cite

MDPI and ACS Style

Myles, L.A.M.; Merlo, E.M. Alexithymia and Physical Outcomes in Psychosomatic Subjects: A Cross-Sectional Study. J. Mind Med. Sci. 2021, 8, 86-93. https://doi.org/10.22543/7674.81.P8693

AMA Style

Myles LAM, Merlo EM. Alexithymia and Physical Outcomes in Psychosomatic Subjects: A Cross-Sectional Study. Journal of Mind and Medical Sciences. 2021; 8(1):86-93. https://doi.org/10.22543/7674.81.P8693

Chicago/Turabian Style

Myles, Liam Alexander MacKenzie, and Emanuele Maria Merlo. 2021. "Alexithymia and Physical Outcomes in Psychosomatic Subjects: A Cross-Sectional Study" Journal of Mind and Medical Sciences 8, no. 1: 86-93. https://doi.org/10.22543/7674.81.P8693

APA Style

Myles, L. A. M., & Merlo, E. M. (2021). Alexithymia and Physical Outcomes in Psychosomatic Subjects: A Cross-Sectional Study. Journal of Mind and Medical Sciences, 8(1), 86-93. https://doi.org/10.22543/7674.81.P8693

Article Metrics

Back to TopTop